Atlas Venture

Massachusetts
Founded in 1980, Atlas Venture has organized seven international funds, and currently manages over $2.0 billion in committed capital, including a $600 million fund raised in April 2001. The Atlas Venture investment team is comprised of operating executives and career venture capitalists who have been involved with more than 350 companies in more than 16 different countries. Since 1995, 50 of Atlas' companies have been acquired and 40 are public. The firm prefers to invest in companies at their earliest stage and focuses on the life sciences and technology industries. Typical investments range from $500,000 to $5 million. Its most current fund, Atlas Venture VIII, is a 2009 vintage for which it held a single close at $283 million. The firm has divided into separate Life Sciences and Technology teams. The Life Sciences group will retain the Atlas name.
Founded:1980
Firm Location:Massachusetts • New York, New York • Boston, Massachusetts • Cambridge, Massachusetts • Boston / New England
Atlas Venture Team
Photo of Peter Barrett, Partner at Atlas Venture
Peter Barrett
Atlas Venture·Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Cambridge (MA)
Photo of Kevin Bitterman, Partner at Atlas Venture
Kevin Bitterman
Atlas Venture·Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Cambridge (MA)
Photo of Bruce Booth, Partner at Atlas Venture
Bruce Booth
Atlas Venture·Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Cambridge (MA)
Photo of Rajesh Devraj, Venture Partner at Atlas Venture
Rajesh Devraj
Atlas Venture·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Maurizio Fazio, Associate at Atlas Venture
Maurizio Fazio
Atlas Venture·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Jean-François Formela, Partner at Atlas Venture
Jean-François Formela
Atlas Venture·Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Cambridge (MA)
Photo of Michael Gladstone, Partner at Atlas Venture
Michael Gladstone
Atlas Venture·Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists)
Photo of Jernej Godec, Senior Associate at Atlas Venture
Jernej Godec
Atlas Venture·Senior Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in United States, Investors in Cambridge (MA), Investors in Boston / New England
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of David Grayzel, Partner at Atlas Venture
David Grayzel
Atlas Venture·Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Cambridge (MA)
Photo of Chelsea Johnson, Senior Associate at Atlas Venture
Chelsea Johnson
Atlas Venture·Senior Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Photo of Jodie Morrison, Venture Partner at Atlas Venture
Jodie Morrison
Atlas Venture·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Massachusetts
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Josh Powers, Associate at Atlas Venture
Josh Powers
Atlas Venture·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Boston (MA)
Investors in FinTech (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Series B), Investors in Boston / New England (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Aimee Raleigh, Associate at Atlas Venture
Aimee Raleigh
Atlas Venture·Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Photo of Samy Ramadane, Analyst at Atlas Venture
Samy Ramadane
Atlas Venture·Analyst
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B)
Photo of Jason Rhodes, Partner at Atlas Venture
Jason Rhodes
Atlas Venture·Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Cambridge (MA)
Photo of Samantha Truex, Venture Partner at Atlas Venture
Samantha Truex
Atlas Venture·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in Boston (MA), Investors in Boston / New England, Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of Lisa Huang, Associate at Atlas Venture
Lisa Huang
Atlas Venture·Associate
Sweet spot: $0
Range: $0 - $0
Investors in Cambridge (MA)
Photo of Steven Robinette, Associate at Atlas Venture
Steven Robinette
Atlas Venture·Associate
Sweet spot: $0
Range: $0 - $0
Investors in Cambridge (MA)
Photo of Phillip Samayoa, Principal at Atlas Venture
Phillip Samayoa
Atlas Venture·Principal
Sweet spot: $0
Range: $0 - $0
Investors in Cambridge (MA)